MicroRNA delivery by cationic lipoplexes for lung cancer therapy. - Wikidata - wikimedia - TriplyDB

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

http://www.wikidata.org/entity/Q34060310

about

Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer Clinical application of microRNA in gastric cancer in Eastern Asian area Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery Can nanomedicines kill cancer stem cells?Nanotechnology in cancer therapy miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth Non-coding RNAs and gastric cancer MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer MicroRNAs as potential therapeutics for treating spinal cord injury.Microemulsion-based synergistic dual-drug codelivery system for enhanced apoptosis of tumor cells.Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin Development of small RNA delivery systems for lung cancer therapy.Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexes Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.Clinical value of microRNA-23a upregulation in non-small cell lung cancer.Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.Morphine and microRNA Activity: Is There a Relation with Addiction?Promises and challenges of MicroRNA-based treatment of multiple myeloma MicroRNAs in Liver Health and Disease Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.In vivo delivery of miRNAs for cancer therapy: challenges and strategies.Smoking and microRNA dysregulation: a cancerous combination.Progress in microRNA delivery.Size Specific Transfection to Mammalian Cells by Micropillar Array Electroporation.Non-coding RNAs in cancer initiation and progression and as novel biomarkers.MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment.MicroRNA silencing and the development of novel therapies for liver disease.MicroRNAs in cancer diagnosis and therapy: from bench to bedside.miRNA-Based Therapeutic Strategies.MicroRNAs in brain metastases: potential role as diagnostics and therapeutics.MicroRNAs in lung cancer.Epigenetic targets for novel therapies of lung diseases.MicroRNA regulatory networks in idiopathic pulmonary fibrosis.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.Overcoming obstacles in microRNA delivery towards improved cancer therapy.MicroRNA Therapeutics: the Next Magic Bullet?The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges.

P2860

Q26744362-66857301-5E66-4FB0-A12B-2B5C1A779333 Q26829583-FAF7F9B8-8E70-4B73-B3F2-A0BD22EA49E5 Q26830434-9D139301-F4EF-48D7-8204-7694BD62DAAA Q27022017-28A7AA2A-89CA-47DB-A2D9-61B4BDEEA850 Q27023013-2DB96EFA-EA9B-463D-9357-06AA7630C762 Q27023295-E511BEDB-DC31-40B1-909C-D3AF79FA528F Q28275778-C6C1E3D9-E116-4F1F-A36D-E459F6E06AF0 Q33594919-F78666D0-5380-46A2-830C-CD4BD5BA6D30 Q34158964-7D063C64-731F-40AE-B4F6-1CBB91EEFE9A Q35020885-8CBF08E7-8364-43DB-B969-1190FC94B53A Q35087984-B848D0AE-8576-4906-B327-A5D9B46B2BDC Q35107566-12EA2213-D13B-4E63-BE7A-51AB464D252B Q35380932-E8FF689B-0A27-4C9B-8C1F-CF43F5D85407 Q35434883-581BC558-2C51-4DD5-B3C0-4CBF1A60DFE7 Q35857347-D8E6C933-045B-4124-ACB7-CCF2235D1619 Q36183170-1061C27A-929F-4C8F-A48B-4CDBEEF89E19 Q36380909-773A6404-3936-4D03-8539-C198FC62D136 Q36386234-933E7D07-61F7-47FB-918D-22C40DE974B0 Q36419086-9806EED1-2B27-456D-BE39-5C292BEC1BDB Q36739805-082B59CE-FAC1-4B16-9CEB-22C5424064E2 Q36832223-D04E44C1-8BB1-4795-892C-264AB70D2C28 Q37063944-8A60F1BD-EB5D-4A30-A4E4-B17A3001214E Q37228217-19BC1637-58FC-4082-B4D7-34BEAE71A059 Q37432727-9DD8F80D-DD10-4AA9-81B1-91DC7F40E90D Q37478933-960BF9E5-2804-4FFA-8113-676A8338182C Q37479832-EF9E2558-929C-4E8A-927C-A8FF5B1A9162 Q37955474-76276672-28F0-498A-B27C-31C73301BF99 Q37985756-030F3013-F9EB-4CBB-834B-21828AA539B9 Q38002726-C00B993C-C564-44D5-B6E8-09A713934F67 Q38057979-4E9A2A50-BC71-4525-A258-611D119F1C5D Q38092617-EC48D96A-0242-4007-9A9B-070467E4628B Q38219675-E903015D-E0A2-44AD-9435-016E39AF9768 Q38261676-3AA4A2CD-D63F-4473-B5B4-AE3361851363 Q38275276-1AE4EE76-AE67-433D-8DF2-7FB6A4DF4969 Q38306947-E6B77DFE-3F60-40DC-A16B-14CCEF7473BC Q38324456-01A929B4-DBBB-4B58-B904-AE8EBF511B0B Q38382967-61EE9FF8-B9F4-4EB3-9A89-AA2497EFEC40 Q38390631-BAECA6A9-627B-4956-8A51-E3A088581944 Q38645695-27D4B212-EA3C-43AB-B92C-53A39D9AE617 Q38734500-48797D18-7841-4681-AF11-0BCC9A5DBC8A

P2860

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

http://www.wikidata.org/entity/Q34060310

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@ast

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@en

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@nl

type

label

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@ast

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@en

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@nl

prefLabel

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@ast

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@en

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@nl

P1433

Q34060310-E0374FCD-856A-41FE-A191-639C74DBA515

P1476

Q34060310-2C496D25-328C-4E72-BB94-FFDDF9C4445E

P2093

Q34060310-3331F03D-7A41-4390-960E-42EAAF2BA361

Q34060310-56ABFA42-198B-4972-9AC6-160CD045C193

Q34060310-57299032-64A5-4444-8296-7C99D240B07D

Q34060310-8806933E-544E-4884-BC35-1E59BBB35A06

Q34060310-C493CE94-4A27-4C65-999C-3B694219E113

Q34060310-E4D199A1-302D-4678-A3B5-A7523B480AF9

P2860

Q34060310-020DE957-A227-45CD-B6AD-31C4A0EF7013

Q34060310-0465471E-13F0-4A6B-BFC2-0CC064C323B6

Q34060310-04E144EA-4DD3-4454-8471-6B5FB277CD36

Q34060310-0AAF0368-3778-4637-A5F9-F8A8CD6D4CB0

Q34060310-0BE943B9-707E-423D-9EFE-F5FBA64059DD

Q34060310-1364F447-5665-48C8-861A-42492F73117E

Q34060310-2D6B219D-BC4F-4CB2-9D28-F50B0C0BCC03

Q34060310-330B0CC6-E962-42EA-BFAB-72BDA0AFF182

Q34060310-3CFB6A6B-92EC-41F0-9394-8D8F7BA9B3EB

Q34060310-3E76F433-E62C-4859-9202-30C81D474713

P304

Q34060310-574412D0-0EB5-4712-86C1-908D86004040

P31

Q34060310-D61456A0-24BA-4898-810F-CA0790494841

P356

Q34060310-CEE9A09B-8283-41E0-AC79-865FDDCC2C80

P407

Q34060310-3160A85D-200E-436D-9742-C931CA249024

P433

Q34060310-A9F4FB85-EB61-4AB1-B64F-8124248BB6AE

P478

Q34060310-B1B7CDF9-3563-4BCE-8A96-A39490B19CF7

P577

Q34060310-42CF7191-A68D-46BC-A147-5E73CB1BFA3E

P5875

Q34060310-745E8F7E-4F20-4825-815A-A60112404F36

P698

Q34060310-15C922B7-278C-4951-8865-18424E2633C8

P921

Q34060310-75FDBA34-2EFC-4964-B4FD-18AEAD8AB45C

P932

Q34060310-D92E0CA4-981E-43ED-9CF3-7E16E846773A

P356

P1433

Molecular Pharmaceutics

P1476

MicroRNA delivery by cationic lipoplexes for lung cancer therapy.

@en

P2093

Bo Yu

http://www.w3.org/2001/XMLSchema#string

L James Lee

http://www.w3.org/2001/XMLSchema#string

Melissa Crawford

http://www.w3.org/2001/XMLSchema#string

Serge P Nana-Sinkam

http://www.w3.org/2001/XMLSchema#string

Yicheng Mao

http://www.w3.org/2001/XMLSchema#string

Yun Wu

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

Suppression of non-small cell lung tumor development by the let-7 microRNA family

RAS is regulated by the let-7 microRNA family

MicroRNAs: small RNAs with a big role in gene regulation

MicroRNA expression profiles classify human cancers

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

The let-7 microRNA represses cell proliferation pathways in human cells

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

P304

1381-1389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/MP2002076

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51198437

http://www.w3.org/2001/XMLSchema#string

P698

21648427

http://www.w3.org/2001/XMLSchema#string

P921

P932

4136514

http://www.w3.org/2001/XMLSchema#string